Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations

Autor: Cortiula, Francesco, De Ruysscher, Dirk, Steens, Michelle, Wijsman, Robin, van der Wekken, Anthonie, Alberti, Martina, Hendriks, Lizza E.L.
Zdroj: In European Journal of Cancer May 2023 184:172-178
Databáze: ScienceDirect